Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Volume: 384, Issue: 5, Pages: 403 - 416
Published: Feb 4, 2021
Abstract
Background null Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19. null Methods null This phase 3 randomized, observer-blinded,...
Paper Details
Title
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Published Date
Feb 4, 2021
Volume
384
Issue
5
Pages
403 - 416
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.